Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS FEATURE

How COVID unlocked the power of RNA vaccines

The technology could revolutionize efforts to immunize against HIV, malaria, influenza and more.
  1. Elie Dolgin
    View author publications

    You can also search for this author in PubMed  Google Scholar

A staff member wearing a orange hi-vis jacket and hard har inspects a vaccines production line

Vaccine manufacturing facilities have had to rapidly ramp up their capabilities to produce RNA vaccines. Credit: Olivier Maire/EPA-EFE/Shutterstock

It was a Friday afternoon in March 2013 when Andy Geall got the call. Three people in China had just become infected with a new strain of avian influenza. The global head of vaccines research at Novartis, Rino Rappuoli, wanted to know whether Geall and his colleagues were ready to put their new vaccine technology to the test.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 589, 189-191 (2021)

doi: https://doi.org/10.1038/d41586-021-00019-w

References

  1. Geall, A. J. et al. Proc. Natl Acad. Sci. USA 109, 14604–14609 (2012).

    Article  PubMed  Google Scholar 

  2. Hekele, A. et al. Emerg. Microbes Infect. 2, e52 (2013).

    Article  PubMed  Google Scholar 

  3. Ulmer, J. B., Mansoura, M. K. & Geall, A. J. Expert Opin. Drug Discov. 10, 101–106 (2015).

    Article  PubMed  Google Scholar 

  4. Martinon, F. et al. Eur. J. Immunol. 23, 1719–1722 (1993).

    Article  PubMed  Google Scholar 

  5. Alberer, M. et al. Lancet 390, 1511–1520 (2017).

    Article  PubMed  Google Scholar 

  6. Feldman, R. A. et al. Vaccine 37, 3326–3334 (2019).

    Article  PubMed  Google Scholar 

  7. Freyn. A. W. et al. Mol. Ther. 28, 1569–1584 (2020).

    Article  PubMed  Google Scholar 

  8. Zhang, N.-N. et al. Cell 182, 1271–1283 (2020).

    Article  PubMed  Google Scholar 

  9. Beissert, T. et al. Mol. Ther. 28, 119–128 (2020).

    Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links